Lucintel’s latest market report analyzed that stent provides attractive opportunities in segments of hospital and ambulatory surgical centers. The stent market is expected to reach $19.8 billion by 2028 with a CAGR of 8.9%. In this market, coronary stent is the largest segment by product type, whereas drug eluting stents is largest by technology. Increasing use of bioreabsorbable stent, increasing adoption of co-polymers as raw materials, and increasing adoption of bifurcated stents provides strategic growth path in this market.
Download Brochure of this report by clicking on https://www.lucintel.com/stents-market.aspx
Based on product type, the stent market is segmented into coronary stent and peripheral vascular stent. The coronary stent segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to increasing cases of cardiovascular disorders.
Browse in-depth TOC on “Stent Market”
74 – Tables
83 – Figures
181 – Pages
The Stent Market is marked by the presence of several big and small players. Some of the prominent players offering stent include Abbott Laboratory, Boston Scientific, Medtronic public limited company, C R Bard, Cook Medical Inc., Terumo Corporation, and Cardinal Health.
Request Sample Report:
https://www.lucintel.com/stents-market.aspx
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. 972.636.5056
Contact Information:
Roy Almaguer Lucintel Dallas, Texas, USA Email: [email protected] Tel. 972.636.5056
Tags:
Reportedtimes, PR-Wirein, Extended Distribution, iCN Internal Distribution, Research Newswire, English